GM-CSF, another MDK-induced cytokine, supports the expansion of immunosuppressive myeloid populations in GBM through IL-4R alpha and is associated with the tumor’s characteristic lymphopenia and systemic immune dysfunction79,80. This evidence concerns the gene CSF2 and lymphopenia.